Sarah Devos, PhD Linkedin Google At a 30,000-foot view, I am a strategic and data-driven Neuroscientist with 15+ years of neurodegenerative translational research experience, spanning several disease indications and numerous therapeutic modalities (oligonucleotides, biologics, ADCs, gene therapy) with >6,000 citations, >10 patents, and 16+ invited talks. But much more importantly, down in the weeds, I […]
Ai-Ling Lin, PhD Google Dr. Ai-Ling Lin is the Vice Chair for Research of the Department of Radiology, Professor of Radiology, Biological Sciences, and Institute for Data Science & Informatics, and a Principal Investigator at the NextGen Precision Health Institute at the University of Missouri- Columbia. Originally from Taiwan, Dr. Lin completed her PhD and Postdoctoral training as a
Rodrigo Medeiros, PhD Since 2007, Rodrigo has led the effort to identify the underlying mechanisms related with the development and progression of neurodegenerative diseases. His long-term goal is to advance knowledge of healthy, and diseased, brain function to a point where rational strategies can be developed for the prevention and cure of age-related neurological disorders.
Rebecca Melrose, PhD Linkedin Google My research uses a combination of MRI (task based fMRI, resting state fMRI, DTI) and neuropsychological testing to understand changes to the neural circuitry supporting executive functioning in patients at risk for Alzheimer’s Disease (AD). I am also interested in understanding changes to day to day functioning in aging and
Swati Rane Levendovszky, PhD Linkedin Twitter Google The primary focus of my research is the development of novel perfusion imaging approaches to better understand cerebrovascular pathology. Specifically, I am interested in investigating the relation of hemodynamic factors such as cerebral blood flow (CBF) and cerebral blood volume (CBV) as well as metabolic demands or oxygen
Swati Rane Levendovszky Read More »
Jennifer Yokoyama, PhD Linkedin Twitter Facebook Google Jennifer Yokoyama obtained her doctorate degree in Pharmaceutical Sciences and Pharmacogenomics from UCSF in December 2010 with Dr. Steven Hamilton (Department of Psychiatry and Institute for Human Genetics). Her dissertation comprised work within the Canine Behavioral Genetics Project, utilizing purebred dogs as genetic models for studying neuropsychiatric disease.
Roger Lefort, PhD Linkedin Twitter The main focus of my lab is to elucidate the molecular mechanism(s) leading to synaptic dysfunction and synaptic pruning in various neurodegenerative diseases, such as Alzheimer’s and Huntington disease. Our research has implicated the Rho-family GTPases, RhoA and Rac1, as key players in these synaptopathies. RhoA and Rac1 play critical
Chadwick Hales, PhD Chad completed a bachelors of science in biochemistry and molecular biology at the University of Georgia in Athens, Georgia, followed by M.D, Ph.D. training at the Medical College of Georgia in Augusta, Georgia. He then moved to Atlanta, Georgia, for internal medicine internship, neurology residency and fellowship in behavioral neurology and neuropsychiatry
Jeremy Herskowitz, PhD Twitter Google Dr. Herskowitz received his B.S. in Chemistry from the University of North Carolina at Chapel Hill in 2001. He earned a Ph.D in Microbiology at Emory University, where he studied mechanisms of gammaherpesvirus pathogenesis in the laboratory of Dr. Samuel Speck. He remained at Emory University for postdoctoral studies and
Syed Abid Hussaini, PhD Linkedin Twitter Google Dr. Hussaini received his PhD in Neurobiology at Freie Universität Berlin, Germany. In his postdoctoral training here at Columbia University in the department of Neuroscience, he studied the function of hippocampal neurons (place cells) and entorhinal cortex neurons (grid cells) which are known to be important for memory
Syed Abid Hussaini Read More »
